🔎 Trials Near Me

Početna › Rak prostate › Ohio › Columbus

Kliničke studije za Rak prostate u gradu Columbus, OH

24 studija za Rak prostate traži sudionike na lokacijama u gradu Columbus i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

U tijeku regrutacijaFaza 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • i još 8
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

U tijeku regrutacijaFaza 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

U tijeku regrutacijaFaza 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • i još 11
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

U tijeku regrutacijaFaza 2/3
  • Central Ohio Urology Group, Gahanna · 7 mi udaljenosti
Od 18 do 100 godina · Muškarci · Ažurirano 22. ruj 2026. · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

U tijeku regrutacijaFaza 3
  • The Ohio State University, Columbus
Od 18 godina i više · Muškarci · Ažurirano 22. ruj 2026. · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

U tijeku regrutacijaFaza 3
  • Central Ohio Urology Group, Gahanna · 7 mi udaljenosti
Od 18 do 100 godina · Muškarci · Ažurirano 22. ruj 2026. · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

U tijeku regrutacijaFaza 3
  • Research Site, Columbus
Od 18 godina i više · Muškarci · Ažurirano 18. ruj 2026. · NCT06952803

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

U tijeku regrutacijaFaza 3
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0061), Columbus
Od 18 godina i više · Muškarci · Ažurirano 17. ruj 2026. · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

U tijeku regrutacijaFaza 3
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Riverside Methodist Hospital, Columbus
  • Grant Medical Center, Columbus
  • i još 4
Od 18 godina i više · Muškarci · Ažurirano 10. ruj 2026. · NCT05946213

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

U tijeku regrutacijaFaza 1/2
  • The Ohio State University, Columbus
Od 18 godina i više · Muškarci · Ažurirano 20. kol 2026. · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

U tijeku regrutacijaFaza 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Muškarci · Ažurirano 19. kol 2026. · NCT04423211

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

U tijeku regrutacijaFaza 1
  • The Ohio State University, Columbus
Od 18 do 100 godina · Muškarci · Ažurirano 13. kol 2026. · NCT05519449

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

U tijeku regrutacijaFaza 1
  • The Ohio State University, Columbus
Od 18 godina i više · Muškarci · Ažurirano 31. srp 2026. · NCT06613100

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

U tijeku regrutacijaFaza 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Muškarci · Ažurirano 14. srp 2026. · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

U tijeku regrutacijaFaza 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Muškarci · Ažurirano 14. srp 2026. · NCT05691465

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

U tijeku regrutacijaFaza 1
  • The Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Muškarci · Ažurirano 9. srp 2026. · NCT07103018

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

U tijeku regrutacijaFaza 1
  • Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
Od 18 godina i više · Oba spola · Ažurirano 8. lip 2026. · NCT04890613

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

U tijeku regrutacijaFaza 1/2
  • Stefanie Spielman Comprehensive Breast Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 27. ožu 2026. · NCT06395519

Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

U tijeku regrutacijaFaza 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Muškarci · Ažurirano 9. ožu 2026. · NCT06330805

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

U tijeku regrutacijaFaza 1/2
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Oba spola · Ažurirano 11. pro 2025. · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

U tijeku regrutacijaOpažajna studija
  • Massive Bio SYNERGY-AI site, Columbus
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

U tijeku regrutacijaFaza 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Od 18 godina i više · Muškarci · Ažurirano 11. ruj 2025. · NCT03678025

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

U tijeku regrutacijaFaza 2
  • Central Ohio Urology Group, Gahanna · 7 mi udaljenosti
Sve dobne skupine · Muškarci · Ažurirano 21. lis 2024. · NCT06636682

Studije za Rak prostate u drugim gradovima

Ostale studije u gradu Columbus

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.